Highlights of the annual meeting of the European Association of Nuclear Medicine, Lausanne 1993
- 1 February 1994
- journal article
- review article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 21 (2) , 159-169
- https://doi.org/10.1007/bf00175765
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Nuclear CardiologyNew England Journal of Medicine, 1993
- Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1993
- Localization of neuroendocrine tumours and insulinomas using radiolabeled somatostatin analogues, 123 I‐Try3‐octreotide and 111in‐pentatreitideClinical Endocrinology, 1993
- Clinical Evaluation of 99mTc Diaminocyclohexane, a Renal Tubular Agent with Cationic Transport: Results in Healthy Human VolunteersNephron, 1993
- Cancer treatment monitoring with fluorine-18 2-fluoro-2-deoxy-d-glucose and positron emission tomography: frustration or futureEuropean Journal of Nuclear Medicine and Molecular Imaging, 1992
- A file format for the exchange of nuclear medicine image dataNuclear Medicine Communications, 1992
- Pituitary imaging using a labelled somatostatin analogue in acromegalyClinical Endocrinology, 1992
- Radiolabelled monoclonal antibodies in oncology I. Technical aspectsNuclear Medicine Communications, 1991
- A prospective study of the use of111In-labelled monoclonal antibody against carcino-embryonic antigen in colorectal cancer and of some biological factors affecting its uptakeInternational Journal of Colorectal Disease, 1989
- Elevated Levels of Glucose Transport and Transporter Messenger RNA Are Induced by ras or src OncogenesScience, 1987